Skip to main content
padlock icon - secure page this page is secure

Therapeutic effects of Lactobacillus casei Qian treatment in activated carboninduced constipated mice

Buy Article:

$42.00 + tax (Refund Policy)

In the present study, the therapeutic effects of Lactobacillus casei Qian (LCQian), the key microorganism in Tibetan yak yoghurt, on activated carboninduced constipation were determined in vivo. ICR mice were treated with LCQian for nine days by oral administration. The body weight, defecation status, gastrointestinal transit and defecation time of mice were assessed, and the serum levels of motilin (MTL), gastrin (Gas), endothelin (ET), somatostatin (SS), acetylcholinesterase (AChE), substance P (SP) and vasoactive intestinal peptide (VIP) were further evaluated. Bisacodyl was used as the positive control. The time until the first black stool defecation following carbon intake of the normal, control, 100 mg/kg bisacodyltreated, Lactobacillus bulgaricus (LB)treated, LCQian (L) and LCQian (H)treated mice was 93, 231, 121, 194, 172 and 157 min, respectively. Following treatment with LCQian, the gastrointestinal transit was increased to 52.4% [LCQian (L)] and 65.8% [LCQian (H)], while that in the group treated with the common lactic acid bacteria of LB was 40.3%. The MTL, Gas, ET, AChE, SP and VIP serum levels were significantly increased and levels of SS were reduced in mice following LCQian treatment compared with those in the control mice (P<0.05). Reverse transcription quantitative polymerase chain reaction indicated that LCQian raised the cKit, GDNF as well as SCF mRNA expression levels and reduced the TRPV1 and NOS expression levels in tissue of the small intestine in mice. These results suggested that lactic acid bacteria prevent constipation in mice, among which LCQian was the most effective.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Affiliations: 1: Department of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, P.R. China 2: College of Food Science, Southwest University, Chongqing 400715, P.R. China 3: Science and Technology Administration, Chinese Academy of Agricultural Sciences, Beijing 100081, P.R. China 4: Institute of QinghaiTibetan Plateau, Southwest University for Nationalities, Chengdu, Sichuan 610041, P.R. China

Publication date: August 1, 2015

More about this publication?
  • Molecular Medicine Reports is a monthly, peer-reviewed journal available in print and online, that includes studies devoted to molecular medicine, underscoring aspects including pharmacology, pathology, genetics, neurosciences, infectious diseases, molecular cardiology and molecular surgery. In vitro and in vivo studies of experimental model systems pertaining to the mechanisms of a variety of diseases offer researchers the necessary tools and knowledge with which to aid the diagnosis and treatment of human diseases.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more